Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications
The estrogen receptor (ER) and/or the human epidermal growth factor receptor 2 (HER2) signaling pathways are the dominant drivers of cell proliferation and survival in the majority of human breast cancers. As a result, targeting these pathways provides the most effective therapies in appropriately s...
Saved in:
Published in | Breast care (Basel, Switzerland) Vol. 8; no. 4; pp. 256 - 262 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger GmbH
01.01.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!